Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
about
The ST2/IL-33 Axis in Immune Cells during Inflammatory Diseases.Pathogenesis of acute graft-versus-host disease: from intestinal microbiota alterations to donor T cell activation.Role of the intestinal mucosa in acute gastrointestinal GVHD.Role of the IL-33-ST2 axis in sepsis.Altered homeostatic regulation of innate and adaptive immunity in lower gastrointestinal tract GVHD pathogenesis.DR3 signaling modulates the function of Foxp3+ regulatory T cells and the severity of acute graft-versus-host disease.Interleukin-33 in health and disease.Role of myeloid-derived suppressor cells in allogeneic hematopoietic cell transplantation.Emerging Roles of IL-33/ST2 Axis in Renal Diseases.Activated protein C protects from GvHD via PAR2/PAR3 signalling in regulatory T-cells.IL-33/ST2 pathway drives regulatory T cell dependent suppression of liver damage upon cytomegalovirus infection.Therapeutic regulatory T-cell adoptive transfer ameliorates established murine chronic GVHD in a CXCR5-dependent manner.Prospects to translate the biology of IL-33 and ST2 during organ transplantation into therapeutics to treat graft-versus-host disease.Interleukin-33 (IL-33): A nuclear cytokine from the IL-1 family.Specifically differentiated T cell subset promotes tumor immunity over fatal immunity.Stereotactic Radiotherapy Increases Functionally Suppressive Regulatory T Cells in the Tumor Microenvironment.Potentiating Tissue-Resident Type 2 Innate Lymphoid Cells by IL-33 to Prevent Renal Ischemia-Reperfusion Injury.Acute Graft-versus-Host Disease - Biologic Process, Prevention, and Therapy.Regulatory T Lymphocytes in Periodontitis: A Translational View.NLRP3 Inflammasome and IL-33: Novel Players in Sterile Liver Inflammation
P2860
Q33593742-00E4C047-FB58-4A8E-A72D-05145A8BC67EQ36130498-A28CBFC1-5FB5-4A2C-A7FF-3D4258811331Q36212428-D9278450-86D2-4DDC-8F61-9C6D6AD7573FQ37620811-6CD9C9FF-7716-413C-8AC0-5652B1113D3FQ38743931-6D1E657D-E185-48AC-A67F-A6157C8EF8CEQ38808955-021FB12D-B18E-4BA8-B70C-D86EF5F16323Q38957840-9E835499-3372-4F14-849E-0BF24ABB2691Q39114090-BE0D7B05-6F09-4D87-831F-6C9E9C85B7D5Q39226501-518C0133-7C99-4E9A-B4B8-0B7DB85D535EQ40085103-509EA495-6436-489F-862E-FB5C8DCE750AQ40225440-BA57D10E-4662-4922-8C79-AD8A8B8CB45FQ41563521-61B497E3-68EF-4861-93CE-3BC0B0DA64B9Q42330812-2CEE65A0-1143-4CDE-80E4-5D8FD21F973CQ47285890-F73ADBF1-975B-43F9-96ED-2943C798F231Q47643463-6ABC8A80-7E5E-4822-9B17-A79E91015BC2Q47880159-86DE8122-E7A9-4F70-B915-044918BB2469Q48319320-FFFDDA2C-BBAC-463A-982E-FCC8060A7FFAQ49679320-F4018C62-77B2-4874-B433-FD5250960C27Q55097930-496039E8-8FB7-4757-BB46-3C484AB89454Q58745474-813A04AF-F07F-4D14-AC85-6DBD3BD83465
P2860
Peri-alloHCT IL-33 administration expands recipient T-regulatory cells that protect mice against acute GVHD.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on 24 May 2016
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@en
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@nl
type
label
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@en
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@nl
prefLabel
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@en
Peri-alloHCT IL-33 administrat ...... otect mice against acute GVHD.
@nl
P2093
P2860
P50
P1433
P1476
Peri-alloHCT IL-33 administrat ...... rotect mice against acute GVHD
@en
P2093
Benjamin M Matta
Brent H Koehn
Colby J Feser
Dietmar Pfeifer
Franziska M Uhl
Gaelen K Dwyer
Jeremy M Lott
Lisa Mathews
Michelle J Smith
P2860
P304
P356
10.1182/BLOOD-2015-12-684142
P407
P577
2016-05-24T00:00:00Z